Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.54 |
| ▸ | MEN1 | O00255 | 5/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.54 |
| ▸ | POLB | P06746 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | EGFR | P00533 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | BLM | P54132 | 2/20 | 0.54 |
| ▸ | RAD52 | P43351 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | NSD2 | O96028 | 2/20 | 0.49 |
| ▸ | FGB | P02675 | 1/20 | 0.49 |
| ▸ | MMP14 | P50281 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2833343 | 0.96 | NSD2 (0.52) | MAPTMEN1KMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL31616869 | 0.95 | MAPT (0.52) | MAPTMEN1KMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL12658877 | 0.95 | MAPT (0.52) | MAPTMEN1KMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL2836129 | 0.95 | TERT (0.48) | MAPTMEN1KMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL30238611 | 0.93 | MAOA (0.52) | MAPTMEN1KMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL2840051 | 0.93 | MAOA (0.52) | MAPTMEN1KMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL22410467 | 0.91 | TERT (0.45) | MAPTMEN1KMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL17717722 | 0.91 | TERT (0.45) | MAPTMEN1KMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL8064424 | 0.90 | MAOA (0.49) | MAPTMEN1KMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL31616824 | 0.90 | MAOA (0.49) | MAPTMEN1KMT2ASMN1; SMN2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9657123-B2 | Photoresist compositions and method of preparing the same | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD (CN) | 2017-05-23 | — | — | US | disclosed |
| US-9657123-B2 | Photoresist compositions and method of preparing the same | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD (CN) | 2017-05-23 | — | — | US | disclosed |
| US-20160122456-A1 | PHOTORESIST COMPOSITIONS AND METHOD OF PREPARING THE SAME | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2016-05-05 | — | — | US | disclosed |
| US-20160122456-A1 | PHOTORESIST COMPOSITIONS AND METHOD OF PREPARING THE SAME | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2016-05-05 | — | — | US | disclosed |
| US-20100110242-A1 | Anthraquinone dye containing material, composition including the same, camera including the same, and associated methods | CHEIL INDUSTRIES, INC. (KR) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100110242-A1 | Anthraquinone dye containing material, composition including the same, camera including the same, and associated methods | ACR, PAM, AAAS | MAPT 1501/4885MEN1 344/4885KMT2A 1033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.